Kedalion Therapeutics, a venture-backed, clinical-stage ophthalmic drug delivery company, is developing the AcuStream technology. The device’s horizontal stream delivers topical ocular drugs precisely and accurately, aiming to reduce required dose by 80% compared with standard drops.
Kedalion Therapeutics, Inc
1490 O’Brien Drive, Suite C
Phone / ContactT: +1 650 461 4503